Does Florida Blue Cover Dupixent?
The verdict
Covered on most plans
Florida Blue (Blue Cross Blue Shield of Florida) covers Dupixent on the specialty tier with prior authorization and step therapy per its formulary. Florida Blue is a single BCBS licensee — a major insurer in the Florida marketplace — and uses Prime Therapeutics as its PBM. Exact tier, step-therapy sequence, and specialty-pharmacy details are Florida-specific; coverage is broad across commercial, Medicare Advantage-PD, and Medicaid lines. Verify on the Florida Blue formulary for your specific plan.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Florida Blue (Blue Cross Blue Shield of Florida) using your member ID.
Key facts
Florida Blue (Blue Cross Blue Shield of Florida) uses Prime Therapeutics as its pharmacy benefit manager — the PBM and specialty-pharmacy network most common among BCBS licensees nationwide.
Florida Blue — formulary and drug-coverage information
Florida Blue is one of the largest individual health insurers in Florida and a major participant in the Florida ACA marketplace, covering Dupixent on the specialty tier for marketplace enrollees.
Florida Blue — plan information
The 2026 Medicare Part D out-of-pocket cap is $2,100; specialty biologic patients who reach it pay $0 for covered drugs for the rest of the calendar year.
CMS.gov — Medicare Part D benefit parameters 2026
Medicare vs. commercial coverage
Whether Florida Blue (Blue Cross Blue Shield of Florida) covers Dupixent depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Florida Blue Medicare Advantage and Part D plans: Dupixent is on the specialty tier with PA and step therapy via Prime Therapeutics. Members pay approximately 25-33% coinsurance after the deductible, capped at $2,100 for 2026 — the plan covers 100% of cost above that cap. Per Sanofi/Regeneron, about 79% of Medicare Part D Dupixent recipients pay $0-$100 per month under post-IRA catastrophic protections. The Dupixent MyWay copay card is not available to Medicare or Medicaid beneficiaries. When Dupixent is administered in a clinic, it may shift to Medicare Part B (medical benefit) rather than Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer plans: Dupixent is covered on the specialty tier (Tier 4 or 5) with PA and indication-specific step therapy via Prime Therapeutics specialty pharmacy. Florida Blue is a major insurer in the Florida ACA marketplace — individuals enrolled in Florida Blue marketplace plans also have access to Dupixent on the specialty tier with PA where offered. The Dupixent MyWay copay card (Sanofi/Regeneron) can reduce commercial member out-of-pocket cost to as little as $0. Medicaid: Florida Blue-affiliated Medicaid plans cover Dupixent per state PDL with PA and step therapy; nominal cost-share. Medical vs. pharmacy benefit: primarily pharmacy-benefit self-injected via Prime Therapeutics specialty network; can flip to Part B/medical benefit when clinic-administered.
The 5 boxes you must tick to get approved
Commercial plans that will consider Dupixent require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Dupixent actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $3,993 per carton of 2 pre-filled pens (list price, Jan 2025 estimate); average retail approximately $5,350-$5,377 per month (estimate). Treat all cash figures as estimates — verify current pricing before use.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial specialty tier: typically 25-33% coinsurance (composite; varies by Florida Blue plan design). Medicare Advantage/Part D: approximately 25-33% coinsurance after deductible, capped at $2,100 for 2026. Medicaid: nominal cost-share. Verify your exact cost-share on your Florida Blue plan documents.
Typical monthly copay once prior authorization is approved.
Bridge program
Dupixent MyWay copay program (Sanofi/Regeneron): as little as $0 per month for eligible commercially insured patients. Not available to Medicare, Medicaid, or other government-plan enrollees. Enroll at dupixent.com/myway or call 1-844-DUPIXENT.
Reduced copay through the assistance program, where eligible.
All copay figures are estimates and vary by Florida Blue plan design and tier. Confirm your actual cost-share by calling the member services number on your Florida Blue insurance card or using the Florida Blue online formulary tool.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search Dupixent on the Florida Blue formulary or drug-lookup tool
Go to floridablue.com and use the drug-lookup or formulary search tool. Search for both 'Dupixent' and 'dupilumab.' Note the tier, any PA or step-therapy requirements, and the Prime Therapeutics specialty-pharmacy designation for your plan type (commercial, Medicare, or marketplace).
- 2
Have your specialist submit a Prior Authorization through Prime Therapeutics
Your allergist, dermatologist, pulmonologist, or gastroenterologist initiates the PA. Clinical documentation must include diagnosis, prior treatment history demonstrating step-therapy completion, current disease severity, and relevant labs (eosinophil count for asthma). The PA is submitted to Prime Therapeutics, Florida Blue's PBM, typically by your physician's office.
- 3
Enroll in Dupixent MyWay if you are commercially insured
After your PA is approved, enroll in the Dupixent MyWay copay program at dupixent.com/myway to reduce your specialty-tier coinsurance to as low as $0. For Medicare beneficiaries, the $2,100 (2026) Part D cap limits annual exposure; the manufacturer card cannot be used on Medicare plans.
Options if Florida Blue (Blue Cross Blue Shield of Florida) won't cover Dupixent
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Topical corticosteroids and calcineurin inhibitors
For atopic dermatitis: required step-therapy agents before Dupixent. Florida Blue's PA criteria typically require documented failure of topical corticosteroids and topical calcineurin inhibitors (tacrolimus, pimecrolimus).
Xolair (omalizumab), Nucala (mepolizumab), Tezspire (tezepelumab)
For asthma: preferred biologics that Florida Blue may require as step therapy before Dupixent, depending on eosinophil phenotype. Confirm the required sequence with Florida Blue's PA criteria or through Prime Therapeutics.
Adbry (tralokinumab) or Dupixent alternatives for atopic dermatitis
Some Florida Blue plans may list alternative IL-4/IL-13 or IL-13 targeted agents. Check the Florida Blue formulary for current preferred specialty biologic positioning for your indication.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes, Florida Blue (Blue Cross Blue Shield of Florida) covers Dupixent on the specialty tier with prior authorization and step therapy via Prime Therapeutics, across commercial, Medicare Advantage, marketplace, and Medicaid lines. Florida Blue is a single BCBS licensee — the specific tier, step-therapy requirements, and specialty-pharmacy details are set by Florida Blue's own formulary, not a national BCBS policy. Verify on the Florida Blue formulary.
Florida Blue uses Prime Therapeutics as its pharmacy benefit manager; Dupixent is dispensed through Prime Therapeutics' specialty-pharmacy network. Prime Therapeutics coordinates home shipment of Dupixent after your PA is approved. Using a non-contracted specialty pharmacy will result in higher cost-share or claim denial. Your PA approval documents and the Florida Blue formulary will confirm the specific dispensing details for your plan.
With Florida Blue commercial insurance, expect specialty-tier coinsurance of approximately 25-33%. The Dupixent MyWay copay card (Sanofi/Regeneron) can reduce this to as low as $0 for eligible commercially insured patients. On Florida Blue Medicare Advantage or Part D, coinsurance is approximately 25-33% after the deductible, capped at $2,100 for 2026. About 79% of Medicare Part D Dupixent recipients pay $0-$100 per month per Sanofi/Regeneron.
Yes, Florida Blue covers Dupixent for all its FDA-approved indications — including moderate-to-severe atopic dermatitis (eczema, age 6 months+) and moderate-to-severe asthma (age 6+) — subject to prior authorization and indication-specific step therapy. The step-therapy requirements differ by indication: topicals for eczema; preferred biologics for asthma. Verify Florida Blue's current PA criteria for each indication on its medical-policy or formulary pages.
Dupixent is primarily dispensed as a self-injected pharmacy-benefit drug through Prime Therapeutics specialty pharmacy. However, when a clinician administers Dupixent in an office or clinical setting, coverage can shift to the medical benefit — billed under Part B for Medicare members or under the medical cost-share for commercial plans. Most patients receive Dupixent as a home self-injection under the pharmacy benefit.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Florida Blue Cover Ozempic? 2026 Coverage Guide | Curex
Florida Blue covers Ozempic for T2D on its GLP-1 diabetes list — explicit commercial weight-loss exclusion. PA steps, copay estimates, 2026 cost facts.
Read moreDoes Florida Blue Cover Wegovy? 2026 Guide | Curex
Florida Blue excludes Wegovy for weight loss on commercial plans. Only the CV indication is covered. Cash and Medicare Bridge options explained.
Read moreDoes Florida Blue Cover Mounjaro? PA Rules 2026 | Curex
Florida Blue covers Mounjaro for type 2 diabetes with PA via Prime Therapeutics' 2025 GLP-1 rule. Not covered for weight loss. FL Medicaid diabetes-only.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Florida Blue (Blue Cross Blue Shield of Florida) before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.